Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 24Lymphoma 16Neoplasms, Plasma Cell 12Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 8Neuroblastoma 7Lymphoma, Mantle-Cell 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Hodgkin Disease 6Myelodysplastic Syndromes 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia 5Burkitt Lymphoma 5Lymphoma, Follicular 4Leukemia, Lymphocytic, Chronic, B-Cell 4Recurrence 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroectodermal Tumors, Primitive 2Medulloblastoma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Biphenotypic, Acute 2Dendritic Cell Sarcoma, Interdigitating 2Brain Neoplasms 2

Interventions

Cyclophosphamide 4pegaspargase 2fludarabine 2Vincristine 2Radiotherapy 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Methotrexate 2Mercaptopurine 2Karyotyping 2Injections, Spinal 2Idarubicin 2Etoposide 2Doxorubicin 2Dexamethasone 2Cytarabine 2Positron Emission Tomography Computed Tomography 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, T-Cell × Melphalan × Clear all
NCT04264078 2021-06-28

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Unknown
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡